Citadel Advisors’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
2022
Q1
$589K Buy
2021
Q4
Sell
2021
Q3
$19.6M Buy
2021
Q2
$17M Buy
2021
Q1
$6.87M Buy